Fundamental Analysis of TENAYA THERAPEUTICS INC(NASDAQ:TNYA) stock

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to TNYA. TNYA was compared to 565 industry peers in the Biotechnology industry. TNYA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TNYA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

TNYA had negative earnings in the past year.

TNYA had a negative operating cash flow in the past year.

TNYA had negative earnings in each of the past 5 years.

TNYA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -83.39%, TNYA is not doing good in the industry: 70.64% of the companies in the same industry are doing better.

With a Return On Equity value of -104.11%, TNYA perfoms like the industry average, outperforming 45.91% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-83.39%
ROE	-104.11%
ROIC	N/A

ROA(3y)-46.75%

ROA(5y)-47.04%

ROE(3y)-55.31%

ROE(5y)-56.6%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TNYA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TNYA has more shares outstanding than it did 1 year ago.

TNYA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

TNYA has an Altman-Z score of -4.34. This is a bad value and indicates that TNYA is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of TNYA (-4.34) is comparable to the rest of the industry.

There is no outstanding debt for TNYA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-4.34

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

TNYA has a Current Ratio of 5.27. This indicates that TNYA is financially healthy and has no problem in meeting its short term obligations.

TNYA has a Current ratio (5.27) which is comparable to the rest of the industry.

A Quick Ratio of 5.27 indicates that TNYA has no problem at all paying its short term obligations.

TNYA has a Quick ratio of 5.27. This is comparable to the rest of the industry: TNYA outperforms 57.47% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.27
Quick Ratio	5.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.40% over the past year.

EPS 1Y (TTM)23.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%23.08%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

TNYA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.09% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y17.47%

EPS Next 2Y11.34%

EPS Next 3Y6.89%

EPS Next 5Y33.09%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TNYA. In the last year negative earnings were reported.

Also next year TNYA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y11.34%

EPS Next 3Y6.89%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TNYA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TENAYA THERAPEUTICS INC

NASDAQ:TNYA (12/23/2024, 1:26:56 PM)

1.625

-0.04 (-2.69%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-06 2024-11-06/amc

Earnings (Next)N/A N/A

Inst Owners72.54%

Inst Owner Change1.34%

Ins Owners1.12%

Ins Owner Change0.33%

Market Cap128.73M

Analysts84

Price Target19.82 (1119.69%)

Short Float %18.05%

Short Ratio2.94

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)17.37%

Min EPS beat(2)14.77%

Max EPS beat(2)19.97%

EPS beat(4)4

Avg EPS beat(4)13.16%

Min EPS beat(4)7.26%

Max EPS beat(4)19.97%

EPS beat(8)8

Avg EPS beat(8)14.66%

EPS beat(12)9

Avg EPS beat(12)8.24%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)22.22%

EPS NY rev (1m)3.1%

EPS NY rev (3m)9.39%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)-100%

Revenue NY rev (1m)-100%

Revenue NY rev (3m)-100%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.14
P/tB	1.14
EV/EBITDA	N/A

EPS(TTM)-1.44

EYN/A

EPS(NY)-1.27

Fwd EYN/A

FCF(TTM)-1.2

FCFYN/A

OCF(TTM)-1.19

OCFYN/A

SpS0

BVpS1.42

TBVpS1.42

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-83.39%
ROE	-104.11%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-46.75%

ROA(5y)-47.04%

ROE(3y)-55.31%

ROE(5y)-56.6%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	14.14%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.27
Quick Ratio	5.27
Altman-Z	-4.34

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)393.92%

Cap/Depr(5y)344.51%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)23.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%23.08%

EPS Next Y17.47%

EPS Next 2Y11.34%

EPS Next 3Y6.89%

EPS Next 5Y33.09%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y8.6%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year16.87%

EBIT Next 3Y-3.43%

EBIT Next 5Y7.55%

FCF growth 1Y27%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y4.12%

OCF growth 3YN/A

OCF growth 5YN/A

TENAYA THERAPEUTICS INC (TNYA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens